<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Evaluation of children with non-chemotherapy-induced neutropenia and fever
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Evaluation of children with non-chemotherapy-induced neutropenia and fever
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Evaluation of children with non-chemotherapy-induced neutropenia and fever
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nabil M Ahmed, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Debra L Palazzi, MD, MEd
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter Newburger, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 06, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with fever and neutropenia should be evaluated promptly because fever may be the first manifestation of a life-threatening infection. The risk of infection in children with non-chemotherapy-induced neutropenia varies with the underlying cause of neutropenia  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         The risk of infection in and evaluation of children with non-chemotherapy-induced neutropenia and fever will be discussed here. The conditions that cause neutropenia in children, the management of children with non-chemotherapy-induced neutropenia and fever, and the evaluation and management of children with chemotherapy-induced neutropenia and fever are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">
          "Overview of neutropenia in children and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6051.html" rel="external">
          "Fever in children with chemotherapy-induced neutropenia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neutropenia
         </strong>
         – Neutropenia is generally defined as an absolute neutrophil count (ANC) &lt;1500 cells/microL. (See
         <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">
          "Overview of neutropenia in children and adolescents", section on 'Definitions and normal values'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The ANC is calculated using the following formula (
         <a class="calc calc_professional" href="/z/d/html/13483.html" rel="external">
          calculator 1
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         ANC = total white blood cell count (cells/microL) x (percent polymorphonuclear cells + percent bands) ÷ 100
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The degree of neutropenia is classified as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mild – ANC 1000 to 1500/microL
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Moderate – ANC 500 to 1000/microL
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe – ANC &lt;500/microL
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The effect of age and race and ethnicity on normal ANC values are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">
          "Overview of neutropenia in children and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fever
         </strong>
         – In neutropenic patients, fever is defined as a single oral temperature ≥38.3°C (101°F), a temperature ≥38°C (100.4°F) for longer than one hour, or two elevations &gt;38°C (100.4°F) during a 12-hour period [
         <a href="#rid1">
          1-3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Rectal measurement of temperature should be avoided in neutropenic patients to avoid the possibility of introducing infection through mucosal trauma. Oral measurement is preferred to other nonrectal sites. An axillary temperature is acceptable if the patient is unable to use an oral thermometer. Noncontact temporal artery/forehead temperature measurements should not be used to make clinical decisions in neutropenic patients. (See
         <a class="medical medical_review" href="/z/d/html/5989.html" rel="external">
          "Fever in infants and children: Pathophysiology and management", section on 'Temperature measurement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2682689200">
         <span class="h1">
          FEVER AND INFECTION IN CHILDREN WITH NEUTROPENIA
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fever as a marker of infection
         </strong>
         – Fever is the most common and often the first clinical manifestation of serious infection in children with neutropenia. It may be the sole sign of occult infection. If a child with neutropenia develops fever, or if a previously healthy child is found to have isolated neutropenia during a febrile illness, the possibility of serious infection must be considered, particularly if the absolute neutrophil count is &lt;1000 cells/microL  (
         <a class="graphic graphic_table graphicRef63903" href="/z/d/graphic/63903.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Serious infection must also be considered in children with neutropenia who are afebrile and ill appearing (eg, hypothermic, hypotensive, listless, confused).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with neutropenia who appear ill or are at increased risk of serious infection should receive empiric antibiotics after blood cultures are obtained. The management of infection in children with non-chemotherapy-induced neutropenia and fever is discussed separately. (See
         <a class="local">
          'Routine cultures'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'Risk-based management approach'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Factors that affect susceptibility to infection
         </strong>
         – Factors that affect susceptibility to infection in children with neutropenia include (see
         <a class="medical medical_review" href="/z/d/html/8375.html" rel="external">
          "Overview of neutropenia in children and adolescents", section on 'Infection propensity'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The degree of neutropenia  (
         <a class="graphic graphic_table graphicRef63903" href="/z/d/graphic/63903.html" rel="external">
          table 2
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Duration of neutropenia [
         <a href="#rid4">
          4,5
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neutrophil function
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ability of the bone marrow to respond to infection
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Function of other components of the immune system
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Integrity of the oral and gastrointestinal mucosa
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presence of central venous catheters, other indwelling devices, or prosthetic implants (eg, Foley catheters, endotracheal tubes)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         These clinical factors, largely determined by the underlying disorder, can be used to categorize the risk of infection in children with non-chemotherapy-induced neutropenia  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H284396591">
         <span class="h1">
          RISK CATEGORIZATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of infection in children with conditions associated with neutropenia that is not due to chemotherapy can be categorized according to the limited information about the frequency and severity of infections and the likelihood of marrow recovery. Factors that affect susceptibility to infection in children with neutropenia include the degree and duration of neutropenia, history and severity of previous infections, neutrophil function, and ability of the bone marrow to respond to an infectious insult and the function of other components of the immune system.
        </p>
        <p class="headingAnchor" id="H3143366996">
         <span class="h2">
          Low risk
         </span>
        </p>
        <p class="headingAnchor" id="H754862738">
         <span class="h3">
          Transient isolated neutropenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transient isolated neutropenia in children may occur during a febrile illness (typically viral) or as an adverse effect of certain medications (eg, antibiotics or anticonvulsants  (
         <a class="graphic graphic_table graphicRef65507" href="/z/d/graphic/65507.html" rel="external">
          table 3
         </a>
         )) [
         <a href="#rid4">
          4,6,7
         </a>
         ]. When due to a viral illness, neutropenia typically resolves within approximately three weeks. (See
         <a class="medical medical_review" href="/z/d/html/8372.html" rel="external">
          "Infectious causes of neutropenia", section on 'Common childhood viral infections'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8374.html" rel="external">
          "Drug-induced neutropenia and agranulocytosis"
         </a>
         .)
        </p>
        <p>
         Children with transient isolated neutropenia are considered to be at low risk of serious infection  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ). Limited evidence from observational studies suggests that when the child appears well, the absolute neutrophil count is ≥500 cells/microL, and the duration of neutropenia is &lt;30 days, serious infection is uncommon [
         <a href="#rid4">
          4,6,8-13
         </a>
         ]. In a retrospective study of 119 well-appearing children without underlying illness who were found to be neutropenic during a minor acute illness, infectious complications developed in 4 of 36 children who were neutropenic for &gt;30 days (two developed stomatitis, one cellulitis, and one pneumonia) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The evaluation and management of children with transient isolated neutropenia and fever are discussed separately. (See
         <a class="local">
          'Evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'Low risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2608688362">
         <span class="h3">
          Chronic autoimmune neutropenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic autoimmune neutropenia of childhood (also known as chronic idiopathic neutropenia and chronic benign neutropenia) typically occurs in children age 5 to 15 months [
         <a href="#rid7">
          7,14,15
         </a>
         ]. Antineutrophil antibodies and spontaneous remission are characteristic. (See
         <a class="medical medical_review" href="/z/d/html/8371.html" rel="external">
          "Immune neutropenia", section on 'Autoimmune neutropenia'
         </a>
         .)
        </p>
        <p>
         Children with chronic autoimmune neutropenia are at low risk of serious bacterial infection  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7,14,16
         </a>
         ]. Most infections in children with chronic autoimmune neutropenia are viral infections and are unrelated to neutropenia.
        </p>
        <p>
         The Italian Neutropenia Registry tracks episodes of meningitis, encephalitis, pneumonia, periodontitis, oral abscesses, deep abdominal infections, bacteremia, fungemia, cutaneous and subcutaneous abscesses, and otomastoiditis that are supported by clinical, imaging, biochemical, and/or microbiologic findings [
         <a href="#rid16">
          16
         </a>
         ]. Among 61 children with autoimmune/idiopathic neutropenia included in the registry, the rate of infection was &lt;1 per 1000 patient days at risk; 19 children had 39 infectious episodes (24 skin and soft tissue infections, 6 episodes of pneumonia; 3 bloodstream infections, 4 infections of the oral cavity, and 2 infections of the ear/nose/throat) [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         Chronic autoimmune neutropenia also may occur in association with a variety of underlying diseases, including infections (eg, hepatitis B, primary abnormalities of B or T lymphocytes, autoimmune hemolytic anemia), especially if late in onset (after age 5 years) or prolonged in duration (longer than three years) [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8371.html" rel="external">
          "Immune neutropenia", section on 'Autoimmune neutropenia'
         </a>
         .)
        </p>
        <p>
         The evaluation and management of children with chronic autoimmune neutropenia/chronic idiopathic neutropenia are discussed separately. (See
         <a class="local">
          'Evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'Low-to-moderate risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3990037185">
         <span class="h2">
          Low-to-moderate risk
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of serious bacterial infection is low to moderate in well-appearing children with chronic autoimmune neutropenia, chronic idiopathic neutropenia, and cyclic neutropenia  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Cyclic neutropenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with cyclic neutropenia who are not treated with granulocyte colony-stimulating factor (G-CSF) experience bouts of severe neutropenia, which last for three to six days, at approximately 21-day intervals [
         <a href="#rid18">
          18-20
         </a>
         ]. During these episodes, they often have fevers, oral ulcers, gingivitis, periodontitis, pharyngitis, adenopathy, and malaise  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ). Meticulous oral hygiene is important in minimizing oral complications. More serious infections such as bacteremia, cellulitis, acute otitis media, sinusitis, pneumonia, or peritonitis occur less frequently [
         <a href="#rid21">
          21
         </a>
         ]. Life-threatening illnesses, particularly necrotizing enterocolitis caused by
         <em>
          Clostridium
         </em>
         <em>
          septicum
         </em>
         [
         <a href="#rid22">
          22,23
         </a>
         ], may occur, although they are uncommon. (See
         <a class="medical medical_review" href="/z/d/html/8370.html" rel="external">
          "Cyclic neutropenia", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
         The prophylactic use of G-CSF reduces the risk and severity of infection [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8370.html" rel="external">
          "Cyclic neutropenia", section on 'G-CSF'
         </a>
         .)
        </p>
        <p>
         The evaluation and management of children with cyclic neutropenia are discussed separately. (See
         <a class="local">
          'Evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'Low-to-moderate risk'
         </a>
         .)f
        </p>
        <p class="headingAnchor" id="H147410152">
         <span class="h2">
          High risk
         </span>
        </p>
        <p class="headingAnchor" id="H3758699424">
         <span class="h3">
          Ill appearance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although fever is the most common and often the first sign of infection, serious infection must also be considered in children with neutropenia who are afebrile and ill appearing (eg, hypothermic, hypotensive, listless, confused).
        </p>
        <p>
         The evaluation and management of ill-appearing children with non-chemotherapy-induced neutropenia are discussed separately. (See
         <a class="local">
          'Evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'High risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Severe congenital neutropenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Severe congenital neutropenia presents shortly after birth with frequent and severe infections. Omphalitis, cellulitis, and perirectal abscesses are common during the first few months of life [
         <a href="#rid24">
          24,25
         </a>
         ]. Disseminated infections, which may be life threatening, are frequently caused by
         <em>
          Staphylococcus aureus
         </em>
         ,
         <em>
          Escherichia coli
         </em>
         , and
         <em>
          Pseudomonas
         </em>
         spp. (See
         <a class="medical medical_review" href="/z/d/html/8373.html" rel="external">
          "Congenital neutropenia", section on 'Severe congenital neutropenia'
         </a>
         .)
        </p>
        <p>
         Children with severe congenital neutropenia are at high risk of serious infection  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ). Among 12 children with severe congenital neutropenia included in the Italian Neutropenia Registry between 2000 and 2009, there were a total of 69 infectious episodes (an average of 5.75 episodes per patient), approximately one-half of which required hospitalization [
         <a href="#rid16">
          16
         </a>
         ]. Skin and soft tissue infections were most common (28 of 69), followed by pneumonia (13 of 69); ear, nose, or throat infection (9 of 69); and bloodstream infection (8 of 69).
        </p>
        <p>
         Prophylactic use of G-CSF reduces, but does not eliminate, the risk and severity of infection. (See
         <a class="medical medical_review" href="/z/d/html/8373.html" rel="external">
          "Congenital neutropenia", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
         Because of the risk of serious infection, patients with severe congenital neutropenia should be evaluated and treated aggressively when febrile. (See
         <a class="local">
          'Evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'High risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Aplastic anemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aplastic anemia is characterized by pancytopenia and hypocellular bone marrow due to injury to or loss of hematopoietic stem cells. Most cases of aplastic anemia in children are acquired and of unclear etiology. Inherited forms of aplastic anemia also occur (eg, Fanconi anemia, Shwachman-Diamond syndrome, dyskeratosis congenita). (See
         <a class="medical medical_review" href="/z/d/html/5923.html" rel="external">
          "Treatment of acquired aplastic anemia in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7152.html" rel="external">
          "Aplastic anemia: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Children with aplastic anemia and fever are at high risk of serious infection  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ). Invasive bacterial or fungal infection is a major cause of death in patients with severe aplastic anemia [
         <a href="#rid26">
          26-28
         </a>
         ]. Neutropenia may last for months to years. (See
         <a class="medical medical_review" href="/z/d/html/5923.html" rel="external">
          "Treatment of acquired aplastic anemia in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7152.html" rel="external">
          "Aplastic anemia: Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Few studies describe infection in children with aplastic anemia and fever. In a sentinel review of 150 patients with aplastic anemia, clinical or microbiologically documented infection occurred in 69 percent of febrile episodes [
         <a href="#rid29">
          29
         </a>
         ]. Infections of the respiratory tract were most common (32 percent), followed by the soft tissues (24 percent), blood (22 percent), gastrointestinal tract (17 percent), and urinary tract (6 percent).
        </p>
        <p>
         In another retrospective multicenter review of 78 children diagnosed with aplastic anemia (6 with nonsevere aplastic anemia), 111 infectious episodes occurred in 42 children [
         <a href="#rid27">
          27
         </a>
         ]. Bacteremia was the most commonly documented infection (23 episodes), followed by pneumonia (13 episodes), severe stomatitis (10 episodes), and 8 skin and soft tissue infections (including central venous catheter/tunnel infections). The distribution of the microbiologically documented isolates was as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gram-positive – 18 episodes overall, 16 bacteremia episodes; gram-positive isolates included
         <em>
          S. aureus
         </em>
         , coagulase negative
         <em>
          Staphylococcus,
         </em>
         and streptococci
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gram-negative – 12 episodes overall, 7 of the bacteremia episodes; gram-negative isolates included the Klebsiella spp,
         <em>
          Enterobacter
         </em>
         spp,
         <em>
          Serratia
         </em>
         spp,
         <em>
          E. coli
         </em>
         , and
         <em>
          Pseudomonas
         </em>
         spp
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Invasive fungal infections – 3 proven/probable and 2 possible infections of the respiratory tract
        </p>
        <p>
        </p>
        <p>
         In a single-center review of 38 episodes of febrile neutropenia in 31 children from India with severe aplastic anemia, frequency and types of documented infectious episodes were similar [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         Children with severe aplastic anemia and fever must receive urgent evaluation and empiric antimicrobial therapy. (See
         <a class="local">
          'Evaluation'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever", section on 'High risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3599582909">
         <span class="h2">
          Neutropenia associated with primary immunodeficiency disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutropenia can occur in association with various other primary immunodeficiency disorders (eg, defects of cellular and humoral immunity, defects of phagocyte number or function, antibody deficiencies). The risk of infection in these disorders and the particular contribution of neutropenia to the risk of infection are not easily categorized given the multitude and variety of disorders. (See
         <a class="medical medical_review" href="/z/d/html/117758.html" rel="external">
          "Inborn errors of immunity (primary immunodeficiencies): Classification"
         </a>
         .)
        </p>
        <p>
         General discussions of the risk, prevention, and management of infection in children with primary immunodeficiency disorders are provided in the topic reviews for specific types of disorders or specific disorders. For example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disorders of phagocyte number and/or function (see
         <a class="medical medical_review" href="/z/d/html/3913.html" rel="external">
          "Primary disorders of phagocyte number and/or function: An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Combined immunodeficiencies (see
         <a class="medical medical_review" href="/z/d/html/3935.html" rel="external">
          "Combined immunodeficiencies: An overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wiskott-Aldrich syndrome (see
         <a class="medical medical_review" href="/z/d/html/3953.html" rel="external">
          "Wiskott-Aldrich syndrome"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Agammaglobulinemia (see
         <a class="medical medical_review" href="/z/d/html/3931.html" rel="external">
          "Agammaglobulinemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1982342483">
         <span class="h3">
          Other conditions associated with neutropenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple other conditions are associated with isolated neutropenia or bone marrow failure. Some of these conditions are associated with a high risk of serious bacterial infection (eg, cartilage hair hypoplasia, reticular dysgenesis, and GATA2 deficiency).
        </p>
        <p class="headingAnchor" id="H3210054665">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with fever and moderate-to-severe neutropenia should be evaluated promptly because they may be at risk for life-threatening infection. The risk and types of infection vary with the underlying cause of neutropenia  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         In children at high risk of infection, the evaluation ideally should occur at a hospital with subspecialty services or at a facility that can arrange for transport to such a facility. Consultations with experts in hematology and/or infectious diseases may be necessary.
        </p>
        <p class="headingAnchor" id="H3187939279">
         <span class="h2">
          History and examination
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          History
         </strong>
         – Important aspects of the history of a child with fever and neutropenia include [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         New site-specific symptoms
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Antimicrobial prophylaxis (affects the choice of empiric antimicrobials)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infection exposures (eg, illness in family members or close contacts)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of documented infections or colonization
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Concomitant noninfectious cause of fever (eg, receipt of blood products)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Underlying conditions that increase the risk of serious infection (eg, diabetes mellitus, recent surgery)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Medication history (eg, glucocorticoids, which may mask fever; antibiotics and/or anticonvulsants, which can cause neutropenia  (
         <a class="graphic graphic_table graphicRef65507" href="/z/d/graphic/65507.html" rel="external">
          table 3
         </a>
         ))
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients who receive prophylactic granulocyte colony-stimulating factor – Adherence to the prescribed regimen and/or recent changes to the regimen
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intravascular catheters or foreign body (increases the risk of infection)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Immunization history (incomplete immunizations or uncertain immunization history may affect the choice of empiric antimicrobials)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical examination
         </strong>
         – A complete physical examination should be performed and repeated periodically (at least once per day in hospitalized children). Signs of inflammation may become evident only when neutrophil counts are recovering.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The physical examination should focus on common sites of infection, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Skin, especially folds, areas surrounding nail beds, and central venous catheter sites including the subcutaneous tunnel, if present
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Mild erythema or tenderness should not be ignored; signs of inflammation in children with neutropenia may be subtle.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sinuses; sinus tenderness (rare in young children) should be evaluated
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oropharynx, especially the gingival line and buccal mucosa (oral ulcers may indicate decreased marrow reserve)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lungs
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abdomen
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perineum, especially the perianal and labial regions
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2288007575">
         <span class="h2">
          Routine cultures
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood cultures – A blood culture should be obtained in all children with fever and moderate-to-severe neutropenia. The culture should be obtained without delay in ill-appearing children and those at high risk of serious bacterial infection  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anaerobic blood culture may be warranted in patients with abdominal signs and symptoms, particularly abdominal pain, and in patients with signs of buccal and perianal infections.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A blood culture should be obtained from each lumen of central catheter ports when such access is available. Although practices may vary from institution to institution, it is also acceptable practice to obtain peripheral blood cultures. Culturing blood from both peripheral and central sites helps to distinguish primary bacteremia from infection related to the catheter and to guide decisions about catheter removal [
         <a href="#rid31">
          31
         </a>
         ]. Diagnosis of intravascular catheter-related infection is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">
          "Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Obtaining a second blood culture can help to differentiate true bacteremia from contamination. True bacteremia is more likely if the same commensal organism (eg, coagulase-negative
         <em>
          Staphylococcus
         </em>
         ) is isolated from ≥2 blood cultures than from a single culture.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other cultures – Which other cultures are routinely obtained from children with fever and non-chemotherapy-induced neutropenia varies from institution to institution. Some experts routinely obtain urine cultures in females or young children who may not complain of urinary tract symptoms. We obtain urine cultures as clinically indicated. (See
         <a class="local">
          'Additional studies as clinically indicated'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6339.html" rel="external">
          "Urine collection techniques in infants and children with suspected urinary tract infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H473098746">
         <span class="h2">
          Additional studies as clinically indicated
         </span>
         <span class="headingEndMark">
          —
         </span>
         Additional studies should be obtained as clinically indicated. Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chest radiographs for children with signs or symptoms of lower respiratory tract infection [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         A chest radiograph without infiltrates should be interpreted with caution since infiltrates may not appear until neutrophil counts are recovering. Patients with ongoing signs and symptoms may require further imaging with magnetic resonance imaging or computed tomography scanning.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rapid and sensitive respiratory diagnostic tests of nasopharyngeal secretions for viruses, as clinically appropriate. For example:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Influenza (see
         <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">
          "Seasonal influenza in children: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">
          "Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Respiratory syncytial virus (see
         <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">
          "Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Adenovirus (see
         <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">
          "Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Severe acute respiratory syndrome coronavirus 2 (see
         <a class="medical medical_review" href="/z/d/html/127488.html" rel="external">
          "COVID-19: Clinical manifestations and diagnosis in children", section on 'Approach to diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrointestinal findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abdominal pain, particularly in children with cyclic neutropenia – Abdominal radiographs and/or ultrasonography (to evaluate
         <em>
          Clostridium
         </em>
         -associated necrotizing enterocolitis) [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diarrhea – Stool bacterial culture and/or polymerase chain reaction (PCR) testing panels,
         <em>
          Clostridioides difficile
         </em>
         toxin assay, and viral PCR testing panels and/or cultures. (See
         <a class="medical medical_review" href="/z/d/html/6048.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in children: Clinical features and diagnosis", section on 'Approach to diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinary symptoms, history of urinary tract infection (UTI), and/or urinary tract abnormalities – Urine culture if not obtained with routine cultures. (See
         <a class="medical medical_review" href="/z/d/html/6339.html" rel="external">
          "Urine collection techniques in infants and children with suspected urinary tract infection"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Urinalysis should not be used to determine the need for urine culture. In a small observational study of children with UTI, pyuria was found in only 1 of 23 neutropenic patients, compared with 21 of 31 without neutropenia [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prolonged neutropenia, persistent diarrhea, or history of parasite exposure – Assay for ova and parasites.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered mental status or meningeal signs – Lumbar puncture; platelet transfusion may be necessary before lumbar puncture in children who have thrombocytopenia as well as neutropenia. Antibiotic therapy should
         <strong>
          not
         </strong>
         be delayed in patients with concern for central nervous system infection but who cannot immediately undergo lumbar puncture. (See
         <a class="medical medical_review" href="/z/d/html/6325.html" rel="external">
          "Lumbar puncture in children", section on 'Contraindications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abscess or sites with drainage – Gram stain and bacterial culture, fungal stain and culture, acid-fast bacilli stain and culture, and possibly fluorescent antibody stains or PCR tests.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2838018992">
         <span class="h2">
          Laboratory tests not routinely recommended
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum galactomannan antigen detection – Serum galactomannan antigen detection is
         <strong>
          not
         </strong>
         routinely recommended in the initial evaluation of children with non-chemotherapy-induced neutropenia and fever because of its poor positive predictive value and inability to exclude non-
         <em>
          Aspergillus
         </em>
         molds [
         <a href="#rid35">
          35,36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Next-generation sequencing – Although data are emerging regarding the utility of next-generation sequencing of microbial cell-free deoxyribonucleic acid (DNA) testing in patients with febrile neutropenia, such testing is not routinely recommended [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions
         </strong>
         – Neutropenia is generally defined as an absolute neutrophil count (ANC) &lt;1500 cells/microL (
         <a class="calc calc_professional" href="/z/d/html/13483.html" rel="external">
          calculator 1
         </a>
         ). In neutropenic patients, fever is defined as a single oral temperature ≥38.3°C (101°F), a temperature ≥38°C (100.4°F) for longer than one hour, or two elevations &gt;38°C (100.4°F) during a 12-hour period. (See
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection in children with neutropenia
         </strong>
         – Although fever is the most common and often the first clinical manifestation of serious infection in children with neutropenia, serious infection can occur in the absence of fever. Factors that affect susceptibility to infection in children with neutropenia include the degree and duration of neutropenia, neutrophil function, the ability of the bone marrow to respond to an infectious insult, and the function of the other components of the immune system. (See
         <a class="local">
          'Fever and infection in children with neutropenia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk categorization
         </strong>
         – The risk and types of infection in children with non-chemotherapy-induced neutropenia vary with the underlying disorder  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Low risk
         </strong>
         – Transient isolated neutropenia in children may be related to a febrile illness (typically viral) or certain medications  (
         <a class="graphic graphic_table graphicRef65507" href="/z/d/graphic/65507.html" rel="external">
          table 3
         </a>
         ). The risk of serious infection in children with transient neutropenia is low, particularly when the child appears well, the ANC is ≥500 cells/microL, and the duration of neutropenia is &lt;30 days. (See
         <a class="local">
          'Transient isolated neutropenia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Children with chronic autoimmune neutropenia (also known as chronic idiopathic neutropenia and chronic benign neutropenia) have a low risk of infection. They typically present with mild infections (eg, upper respiratory tract infection, otitis media, skin infection) but may (very rarely) develop serious bacterial infections (eg, pneumonia, meningitis, sepsis). (See
         <a class="local">
          'Chronic autoimmune neutropenia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Low-to-moderate risk
         </strong>
         – Children with cyclic neutropenia have a low-to-moderate risk of infection. During episodes of neutropenia they often have fevers, oral ulcers, gingivitis, periodontitis, lymphadenopathy, and malaise. More serious infections (eg, bacteremia, cellulitis, acute otitis media, pneumonia, peritonitis) occur less frequently. Life-threatening illnesses (eg,
         <em>
          Clostridium septicum
         </em>
         necrotizing enterocolitis) are uncommon. Uncharacteristic fever patterns, atypical oral lesions, and localized findings, particularly abdominal pain, during the neutrophil nadir should increase suspicion for more serious infection. (See
         <a class="local">
          'Cyclic neutropenia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          High risk
         </strong>
         – Ill-appearing children, children with severe congenital neutropenia, children with acquired or inherited aplastic anemia, and children with other conditions associated with neutropenia (eg, bone marrow failure and immunodeficiency syndromes) are at high risk for infection. The types of infection vary with the underlying disorder  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'High risk'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – Children with non-chemotherapy-induced neutropenia and fever should be evaluated promptly because fever may be the first manifestation of a life-threatening infection. The risk and types of infection vary with the underlying cause of neutropenia  (
         <a class="graphic graphic_table graphicRef65091" href="/z/d/graphic/65091.html" rel="external">
          table 1
         </a>
         ). Repeated examination of the most common sites of infection (eg, skin, sinuses, oropharynx, lungs, abdomen, and perineum) is essential. (See
         <a class="local">
          'History and examination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We routinely obtain blood cultures in children with non-chemotherapy-induced neutropenia and fever. For children with central catheters, we obtain blood cultures from each lumen and peripheral blood cultures. We obtain additional studies (eg, chest radiograph, viral studies, urine cultures) as clinically indicated. (See
         <a class="local">
          'Routine cultures'
         </a>
         above and
         <a class="local">
          'Additional studies as clinically indicated'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – The management of children with non-chemotherapy-induced neutropenia and fever is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6059.html" rel="external">
          "Management of children with non-chemotherapy-induced neutropenia and fever"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Wolff LJ, Ablin AR, Altman AJ, Johnson FL. The management of fever. In: Supportive care of children with cancer: Current therapy and guidelines from the Children's Cancer Group, 2nd ed, Ablin AR (Ed), Johns Hopkins University Press, Baltimore 1997. p.23.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinberger M. Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies. Hematol Oncol Clin North Am 1993; 7:865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011; 52:e56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alario AJ, O'Shea JS. Risk of infectious complications in well-appearing children with transient neutropenia. Am J Dis Child 1989; 143:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexandropoulou O, Kossiva L, Haliotis F, et al. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up. Eur J Pediatr 2013; 172:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindqvist H, Carlsson G, Moell J, et al. Neutropenia in childhood: a 5-year experience at a tertiary center. Eur J Pediatr 2015; 174:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serwint JR, Dias MM, Chang H, et al. Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting. Clin Pediatr (Phila) 2005; 44:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barg AA, Kozer E, Mordish Y, et al. The Risk of Serious Bacterial Infection in Neutropenic Immunocompetent Febrile Children. J Pediatr Hematol Oncol 2015; 37:e347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pascual C, Trenchs V, Hernández-Bou S, et al. Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department. Eur J Clin Microbiol Infect Dis 2016; 35:1667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wittmann O, Rimon A, Scolnik D, Glatstein M. Outcomes of Immunocompetent Children Presenting with Fever and Neutropenia. J Emerg Med 2018; 54:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia. Acad Emerg Med 2010; 17:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagalapuram V, McCall D, Palabindela P, et al. Outcomes of Isolated Neutropenia Referred to Pediatric Hematology-Oncology Clinic. Pediatrics 2020; 146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farruggia P, Fioredda F, Puccio G, et al. Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry. Am J Hematol 2019; 94:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newburger PE. Autoimmune and other acquired neutropenias. Hematology Am Soc Hematol Educ Program 2016; 2016:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fioredda F, Calvillo M, Burlando O, et al. Infectious complications in children with severe congenital, autoimmune or idiopathic neutropenia: a retrospective study from the Italian Neutropenia Registry. Pediatr Infect Dis J 2013; 32:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fioredda F, Rotulo GA, Farruggia P, et al. Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry. Blood Adv 2020; 4:5644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makaryan V, Zeidler C, Bolyard AA, et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol 2015; 22:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dale DC, Bolyard A, Marrero T, et al. Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia. N Engl J Med 2017; 377:2290.
          </a>
         </li>
         <li class="breakAll">
          Dale DC, Makaryan V.. GeneReviews®, Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A. (Eds), University of Washington, Seattle, Seattle (WA) 1993.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dale DC, Hammond WP 4th. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins DG, Kushner JP. Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia. Am J Hematol 1983; 14:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bar-Joseph G, Halberthal M, Sweed Y, et al. Clostridium septicum infection in children with cyclic neutropenia. J Pediatr 1997; 131:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kostman R. Infantile genetic agranulocytosis. A review with presentation of ten new cases. Acta Paediatr Scand 1975; 64:362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skokowa J, Dale DC, Touw IP, et al. Severe congenital neutropenias. Nat Rev Dis Primers 2017; 3:17032.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torres HA, Bodey GP, Rolston KV, et al. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 2003; 98:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quarello P, Saracco P, Giacchino M, et al. Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy. Eur J Haematol 2012; 88:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valdez JM, Scheinberg P, Nunez O, et al. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis 2011; 52:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinberger M, Elattar I, Marshall D, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992; 71:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samanta A, Chandra J, Kaur R, et al. Clinical Profile and Microbiologic Spectrum of Febrile Neutropenic Episodes in Children With Severe Aplastic Anemia. J Pediatr Hematol Oncol 2020; 42:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Franklin JA, Gaur AH, Shenep JL, et al. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J 2004; 23:614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korones DN. Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer? Pediatr Blood Cancer 2004; 43:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarville MB, Adelman CS, Li C, et al. Typhlitis in childhood cancer. Cancer 2005; 104:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klaassen IL, de Haas V, van Wijk JA, et al. Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer 2011; 56:868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol 2017; 35:2082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lehrnbecher T, Robinson PD, Fisher BT, et al. Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Clin Infect Dis 2016; 63:1340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benamu E, Gajurel K, Anderson JN, et al. Performance of the Karius plasma next generation sequencing test in determining the etiologic diagnosis of febrile neutropenia: Results from a pilot study. Open Forum Infect Dis 2017; 4(Suppl 1):S613.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6058 Version 22.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Wolff LJ, Ablin AR, Altman AJ, Johnson FL. The management of fever. In: Supportive care of children with cancer: Current therapy and guidelines from the Children's Cancer Group, 2nd ed, Ablin AR (Ed), Johns Hopkins University Press, Baltimore 1997. p.23.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8354659" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21258094" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2756974" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Risk of infectious complications in well-appearing children with transient neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7058815" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23408310" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25435257" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Neutropenia in childhood: a 5-year experience at a tertiary center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16151565" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25929615" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The Risk of Serious Bacterial Infection in Neutropenic Immunocompetent Febrile Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27319003" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29242012" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Outcomes of Immunocompetent Children Presenting with Fever and Neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20070267" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Risk of serious bacterial infection in isolated and unsuspected neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32883808" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Outcomes of Isolated Neutropenia Referred to Pediatric Hematology-Oncology Clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30456824" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27913460" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Autoimmune and other acquired neutropenias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23249920" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Infectious complications in children with severe congenital, autoimmune or idiopathic neutropenia: a retrospective study from the Italian Neutropenia Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33206964" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25427142" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29211670" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29211670" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3052663" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Cyclic neutropenia: a clinical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6846331" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9290625" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Clostridium septicum infection in children with cyclic neutropenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1130195" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Infantile genetic agranulocytosis. A review with presentation of ten new cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28593997" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Severe congenital neutropenias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12833460" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Infections in patients with aplastic anemia: experience at a tertiary care cancer center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22381133" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21367725" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1549057" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32209945" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Clinical Profile and Microbiologic Spectrum of Febrile Neutropenic Episodes in Children With Severe Aplastic Anemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15247598" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15481080" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15952190" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Typhlitis in childhood cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20949597" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Pyuria is absent during urinary tract infections in neutropenic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28459614" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27567122" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Galactomannan,β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Performance of the Karius plasma next generation sequencing test in determining the etiologic diagnosis of febrile neutropenia: Results from a pilot study
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
